Arne Scholz
- Oncology top 2%
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Cancer Research top 5%
- Co-authors
- Bertram WiedenmannStefan RosewiczDominik MumbergKatharina DetjenPeter HauffChristoph BenckertPetra SchulzZofia von Marschall
- Topics
- Radiopharmaceutical Chemistry and Applications (20 papers)Prostate Cancer Treatment and Research (17 papers)Cancer-related Molecular Pathways (10 papers)
- Partner nations
- GermanyUnited StatesFinland
In The Last Decade
Arne Scholz
62 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 92
- Oncology 995
- Molecular Biology 714
- Pulmonary and Respiratory Medicine 490
- Radiology, Nuclear Medicine and Imaging 412
- Cancer Research 319
Countries citing papers authored by Arne Scholz
This map shows the geographic impact of Arne Scholz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arne Scholz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arne Scholz more than expected).
Fields of papers citing papers by Arne Scholz
This network shows the impact of papers produced by Arne Scholz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arne Scholz. The network helps show where Arne Scholz may publish in the future.
Co-authorship network of co-authors of Arne Scholz
This figure shows the co-authorship network connecting the top 25 collaborators of Arne Scholz. A scholar is included among the top collaborators of Arne Scholz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arne Scholz. Arne Scholz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 1 | |
| 3 | 4 | |
| 4 | 2 | |
| 5 | 49 | |
| 6 | 96 | |
| 7 | 137 | |
| 8 | 2 | |
| 9 | 5 | |
| 10 | 1 | |
| 11 | 51 | |
| 12 | 15 | |
| 13 | 72 | |
| 14 | 28 | |
| 15 | 56 | |
| 16 | 9 | |
| 17 | Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer. | 75 |
| 18 | 35 | |
| 19 | 47 | |
| 20 | 204 |
About Arne Scholz
Arne Scholz is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 64 papers that have together received 1.9k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (20 papers), Prostate Cancer Treatment and Research (17 papers) and Cancer-related Molecular Pathways (10 papers). The work is most often cited by research in Oncology (995 citations), Cancer Research (319 citations) and Radiology, Nuclear Medicine and Imaging (412 citations). Arne Scholz has collaborated with scholars based in Germany, United States and Finland. Frequent co-authors include Bertram Wiedenmann, Stefan Rosewicz, Dominik Mumberg, Katharina Detjen, Peter Hauff, Christoph Benckert, Petra Schulz, Zofia von Marschall, Michael Schirner and Karl Ziegelbauer. Their work appears in journals such as Blood, Gastroenterology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.